BNP Paribas Financial Markets’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
BNP Paribas Financial Markets's OGN Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Organon & Co (OGN) stake by 169% in Q2 2026, buying an estimated $2.93M and bringing the position to 390,745 shares worth $5.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2061.
BNP Paribas Financial Markets first reported a position in OGN in Q3 2022 and has held it in 9 quarters since. The position peaked at $10.2M in Q3 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- BNP Paribas Financial Markets held 390,745 shares of Organon & Co worth $5.29M as of Q2 2026.
- BNP Paribas Financial Markets bought 245,300 Organon & Co shares in Q2 2026, an estimated $2.93M.
- Organon & Co made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2061 holding.
- BNP Paribas Financial Markets first reported a position in Organon & Co in Q3 2022 and has held it in 9 quarters since.
- BNP Paribas Financial Markets's Organon & Co position peaked at $10.2M in Q3 2025.
- 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.